| Amgen Switzerland AG - Amgevita 40 mg/0.4 ml, Injektionslösung in einer Fertigspritze |
| 66979 | | 05 | | Amgevita 40 mg/0.4 ml | | Injektionslösung in einer Fertigspritze | | L04AB04 | | Adalimumab | | 22.02.2024 | | |
|
| Composition |
| adalimumabum 40 mg, saccharum, polysorbatum 80, acidum lacticum, natrii hydroxidum corresp. natrium max. 0.22 mg, aqua ad iniectabile q.s. ad solutionem pro 0.4 ml. |
| Packungsbestandteile |
| Solution injectable en seringue prête à l'emploi | | | | | | | | Principe actif | Concentr. |
|---|
| Adalimumab | 40mg / 0.4ml |
| | BAG: Principe actif | Concentr. |
|---|
| Adalimumab | 40 mg |
| | | | Agents auxilliaires |
|---|
| Acide Lactique | | Sodium Hydroxide | | Polysorbatum 80 | | Saccharum |
| |
|
|
